Topics

Gossamer Bio Announces Data Presentations at the Congress of the European Crohn's and Colitis Organisation

07:04 EST 13 Feb 2020 | FinanzNachrichten

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inf...

Original Article: Gossamer Bio Announces Data Presentations at the Congress of the European Crohn's and Colitis Organisation

NEXT ARTICLE

More From BioPortfolio on "Gossamer Bio Announces Data Presentations at the Congress of the European Crohn's and Colitis Organisation"

Quick Search

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...